Senti Biosciences (SNTI) Competitors $1.35 -0.04 (-2.88%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.38 +0.02 (+1.85%) As of 09/19/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNTI vs. FBRX, ZURA, GNLX, ADAG, PLX, SKYE, CGEN, BHST, IKT, and TARAShould you be buying Senti Biosciences stock or one of its competitors? The main competitors of Senti Biosciences include Forte Biosciences (FBRX), Zura Bio (ZURA), Genelux (GNLX), Adagene (ADAG), Protalix BioTherapeutics (PLX), Skye Bioscience (SKYE), Compugen (CGEN), BioHarvest Sciences (BHST), Inhibikase Therapeutics (IKT), and Protara Therapeutics (TARA). These companies are all part of the "pharmaceutical products" industry. Senti Biosciences vs. Its Competitors Forte Biosciences Zura Bio Genelux Adagene Protalix BioTherapeutics Skye Bioscience Compugen BioHarvest Sciences Inhibikase Therapeutics Protara Therapeutics Forte Biosciences (NASDAQ:FBRX) and Senti Biosciences (NASDAQ:SNTI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends. Which has more risk and volatility, FBRX or SNTI? Forte Biosciences has a beta of 2.69, suggesting that its stock price is 169% more volatile than the S&P 500. Comparatively, Senti Biosciences has a beta of 2.06, suggesting that its stock price is 106% more volatile than the S&P 500. Is FBRX or SNTI more profitable? Forte Biosciences' return on equity of -85.38% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Forte BiosciencesN/A -85.38% -72.34% Senti Biosciences N/A -223.98%-76.02% Which has preferable earnings & valuation, FBRX or SNTI? Forte Biosciences has higher earnings, but lower revenue than Senti Biosciences. Forte Biosciences is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForte BiosciencesN/AN/A-$35.48M-$16.29-0.83Senti Biosciences$2.56M13.80-$52.79M-$8.95-0.15 Do analysts rate FBRX or SNTI? Forte Biosciences currently has a consensus target price of $68.00, suggesting a potential upside of 403.33%. Senti Biosciences has a consensus target price of $8.50, suggesting a potential upside of 529.63%. Given Senti Biosciences' higher probable upside, analysts clearly believe Senti Biosciences is more favorable than Forte Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Senti Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of FBRX or SNTI? 77.6% of Forte Biosciences shares are held by institutional investors. Comparatively, 25.7% of Senti Biosciences shares are held by institutional investors. 5.9% of Forte Biosciences shares are held by insiders. Comparatively, 3.1% of Senti Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor FBRX or SNTI? In the previous week, Forte Biosciences had 2 more articles in the media than Senti Biosciences. MarketBeat recorded 3 mentions for Forte Biosciences and 1 mentions for Senti Biosciences. Forte Biosciences' average media sentiment score of 0.67 beat Senti Biosciences' score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forte Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Senti Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryForte Biosciences beats Senti Biosciences on 9 of the 13 factors compared between the two stocks. Get Senti Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNTI vs. The Competition Export to ExcelMetricSenti BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$36.36M$3.16B$5.80B$10.40BDividend YieldN/A2.37%5.63%4.60%P/E Ratio-0.1520.7876.8226.78Price / Sales13.80447.76532.95124.28Price / CashN/A46.6037.9961.55Price / Book0.259.6613.746.40Net Income-$52.79M-$53.13M$3.30B$271.80M7 Day PerformanceN/A3.11%2.65%3.48%1 Month Performance-14.56%7.56%6.04%9.89%1 Year Performance-57.14%11.15%80.14%28.51% Senti Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNTISenti Biosciences2.5689 of 5 stars$1.35-2.9%$8.50+529.6%-56.9%$36.36M$2.56M-0.154News CoverageShort Interest ↓High Trading VolumeFBRXForte Biosciences3.1379 of 5 stars$11.15+0.1%$68.00+510.1%+92.9%$138.53MN/A-0.685Options VolumeGap UpZURAZura Bio3.5987 of 5 stars$2.14-3.3%$14.00+555.1%-53.7%$138.17MN/A-3.043Short Interest ↓GNLXGenelux0.974 of 5 stars$3.59+0.8%$20.33+466.5%+75.5%$135.56M$10K-4.1710Positive NewsADAGAdagene3.0887 of 5 stars$2.82+17.8%$7.00+148.7%-8.9%$132.67M$100K0.00260News CoverageHigh Trading VolumePLXProtalix BioTherapeutics1.8811 of 5 stars$1.66+4.7%$15.00+806.3%+64.3%$131.96M$61.95M-12.73200Positive NewsSKYESkye Bioscience1.8258 of 5 stars$4.120.0%$15.50+276.4%-27.1%$127.62MN/A-3.8811CGENCompugen1.0407 of 5 stars$1.42-2.4%$4.00+182.7%-27.7%$126.28M$27.86M-6.4370BHSTBioHarvest SciencesN/A$7.38+3.4%$13.67+85.2%N/A$121.18M$25.19M-10.54N/AGap UpIKTInhibikase Therapeutics1.2745 of 5 stars$1.62-2.4%$6.50+301.2%+41.4%$120.72MN/A-0.616TARAProtara Therapeutics1.2185 of 5 stars$3.08+0.2%$19.60+537.4%+61.9%$118.63MN/A-1.9030 Related Companies and Tools Related Companies Forte Biosciences Alternatives Zura Bio Alternatives Genelux Alternatives Adagene Alternatives Protalix BioTherapeutics Alternatives Skye Bioscience Alternatives Compugen Alternatives BioHarvest Sciences Alternatives Inhibikase Therapeutics Alternatives Protara Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNTI) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNTI Stock Alerts